Terms: = Breast cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
316 results:
1. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
2. Biological Basis of breast cancer-Related Disparities in Precision Oncology Era.
Neagu AN; Bruno P; Johnson KR; Ballestas G; Darie CC
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612922
[TBL] [Abstract] [Full Text] [Related]
3. Safety of COVID-19 Vaccination in Patients With breast cancer: Cross-Sectional Study in China.
Zhang S; Li J; Xu R; Chen Q; Sun G; Lin Y; Cao Y; Chen Y; Geng C; Teng Y; Nie J; Li X; Xu G; Liu X; Jin F; Fan Z; Luo T; Liu H; Wang FS; Jiang Z
JMIR Public Health Surveill; 2023 Dec; 9():e46009. PubMed ID: 38060302
[TBL] [Abstract] [Full Text] [Related]
4. Increase in the Life Expectancy of Patients with cancer in the United States.
Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
[TBL] [Abstract] [Full Text] [Related]
5. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for breast cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract] [Full Text] [Related]
6. Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
Rediti M; Fernandez-Martinez A; Venet D; Rothé F; Hoadley KA; Parker JS; Singh B; Campbell JD; Ballman KV; Hillman DW; Winer EP; El-Abed S; Piccart M; Di Cosimo S; Symmans WF; Krop IE; Salgado R; Loi S; Pusztai L; Perou CM; Carey LA; Sotiriou C
Nat Commun; 2023 Nov; 14(1):7053. PubMed ID: 37923752
[TBL] [Abstract] [Full Text] [Related]
7. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
Tawfik B; Dayao ZR; Brown-Glaberman UA; Pankratz VS; Lafky JM; Loprinzi CL; Barton DL
Support Care Cancer; 2023 Oct; 31(12):637. PubMed ID: 37847317
[TBL] [Abstract] [Full Text] [Related]
8. Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study.
Simon TA; Suissa S; Boers M; Hochberg MC; Skovron ML; Askling J; Michaud K; Strangfeld A; Pedro S; Frisell T; Meissner Y; Dominique A; Gomez A
Semin Arthritis Rheum; 2024 Feb; 64():152240. PubMed ID: 37500379
[TBL] [Abstract] [Full Text] [Related]
9. Ponatinib: An update on its drug targets, therapeutic potential and safety.
Gao Y; Ding Y; Tai XR; Zhang C; Wang D
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188949. PubMed ID: 37399979
[TBL] [Abstract] [Full Text] [Related]
10. Molecular subtypes as a prognostic breast cancer factor in women users of the São Paulo public health system, Brazil.
Peres SV; Arantes PE; Fagundes MA; Ab'Saber AM; Gimenes DL; Curado MP; Vieira RADC
Rev Bras Epidemiol; 2023; 26():e230028. PubMed ID: 37255208
[TBL] [Abstract] [Full Text] [Related]
11. Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study.
Alkan ŞB; Artaç M; Aksoy F; Belviranlı MM; Gürbilek M; Çizmecioğlu HA; Rakıcıoğlu N
Support Care Cancer; 2023 May; 31(6):334. PubMed ID: 37183232
[TBL] [Abstract] [Full Text] [Related]
12. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
[TBL] [Abstract] [Full Text] [Related]
13. Progress Against cancer in Kuwait: Trends in Incidence, Survival and Mortality.
E A; A AA; A E; P CM; C A
Gulf J Oncolog; 2023 Jan; 1(41):23-31. PubMed ID: 36804156
[TBL] [Abstract] [Full Text] [Related]
14. Low Expression of BRCA1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic Leukemia.
Villegas-Ruíz V; Medina-Vera I; Arellano-Perdomo P; Castillo-Villanueva A; Galván-Diaz CA; Paredes-Aguilera R; Rivera-Luna R; Juárez-Méndez S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e167-e173. PubMed ID: 36730467
[TBL] [Abstract] [Full Text] [Related]
15. PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.
Li C; Hao M; Fang Z; Ding J; Duan S; Yi F; Wei Y; Zhang W
Cancer Chemother Pharmacol; 2023 Mar; 91(3):203-217. PubMed ID: 36725727
[TBL] [Abstract] [Full Text] [Related]
16. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With breast cancer.
Tagliamento M; Gennari A; Lambertini M; Salazar R; Harbeck N; Del Mastro L; Aguilar-Company J; Bower M; Sharkey R; Dalla Pria A; Plaja A; Jackson A; Handford J; Sita-Lumsden A; Martinez-Vila C; Matas M; Miguel Rodriguez A; Vincenzi B; Tonini G; Bertuzzi A; Brunet J; Pedrazzoli P; D'Avanzo F; Biello F; Sinclair A; Lee AJX; Rossi S; Rizzo G; Mirallas O; Pimentel I; Iglesias M; Sanchez de Torre A; Guida A; Berardi R; Zambelli A; Tondini C; Filetti M; Mazzoni F; Mukherjee U; Diamantis N; Parisi A; Aujayeb A; Prat A; Libertini M; Grisanti S; Rossi M; Zoratto F; Generali D; Saura C; Lyman GH; Kuderer NM; Pinato DJ; Cortellini A
J Clin Oncol; 2023 May; 41(15):2800-2814. PubMed ID: 36720089
[TBL] [Abstract] [Full Text] [Related]
17. Hodgkin Lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up.
Kourti M; Papakonstantinou E; Papagianni A; Arsos G; Ioannidou M; Pantoleon A; Antari V; Palabougiouki M; Kouskouras K; Venizelos I; Κoletsa T; Cheva A; Anastasiou A; Totikidis G; Tragiannidis A; Galli-Tsinopoulou A; Hatzipantelis E
J Pediatr Hematol Oncol; 2023 Aug; 45(6):322-326. PubMed ID: 36716084
[TBL] [Abstract] [Full Text] [Related]
18. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Wilkins A; Gusterson B; Tovey H; Griffin C; Stuttle C; Daley F; Corbishley CM; Dearnaley D; Hall E; Somaiah N
EBioMedicine; 2023 Feb; 88():104436. PubMed ID: 36708693
[TBL] [Abstract] [Full Text] [Related]
19. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-breast cancer Effects.
Ciftci H; Sever B; Kaya N; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615273
[TBL] [Abstract] [Full Text] [Related]
20. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
[Next]
